These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 33790729)

  • 1. Cognitive Impairment After Resolution of Hepatic Encephalopathy: A Systematic Review and Meta-Analysis.
    López-Franco Ó; Morin JP; Cortés-Sol A; Molina-Jiménez T; Del Moral DI; Flores-Muñoz M; Roldán-Roldán G; Juárez-Portilla C; Zepeda RC
    Front Neurosci; 2021; 15():579263. PubMed ID: 33790729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of cognitive impairment in cirrhotic patients with bacterial infections.
    Merli M; Lucidi C; Pentassuglio I; Giannelli V; Giusto M; Di Gregorio V; Pasquale C; Nardelli S; Lattanzi B; Venditti M; Riggio O
    J Hepatol; 2013 Aug; 59(2):243-50. PubMed ID: 23523580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation significantly improves global functioning and cerebral processing.
    Ahluwalia V; Wade JB; White MB; Gilles HS; Heuman DM; Fuchs M; Gavis EA; Fagan A; Tinsley F; Ganapathy D; Thacker LR; Sterling RK; Stravitz RT; Puri P; Sanyal AJ; Siddiqui MS; Matherly S; Luketic V; Steinberg J; Moeller FG; Bajaj JS
    Liver Transpl; 2016 Oct; 22(10):1379-90. PubMed ID: 27339647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effects of Helicobacter pylori infection on hyperammonaemia and hepatic encephalopathy in cirrhotic patients].
    Wang LJ; Cai JT; Chen T; Lü B; Si JM
    Zhonghua Nei Ke Za Zhi; 2006 Aug; 45(8):654-7. PubMed ID: 17074151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance characterization of a novel electronic number connection test to detect minimal hepatic encephalopathy in cirrhotic patients.
    Wuensch T; Ruether DF; Zöllner C; Mueller T; Jung T; Kaffarnik M; Kassner U; Schott E; Kiefer S; Pratschke J; Stockmann M; Jara M
    Eur J Gastroenterol Hepatol; 2017 Apr; 29(4):456-463. PubMed ID: 28092641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is sarcopenia associated with hepatic encephalopathy in liver cirrhosis? A systematic review and meta-analysis.
    Chang KV; Chen JD; Wu WT; Huang KC; Lin HY; Han DS
    J Formos Med Assoc; 2019 Apr; 118(4):833-842. PubMed ID: 30279030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a three-factor neuropsychological approach for detecting minimal hepatic encephalopathy.
    Stewart CA; Enders FT; Schneider N; Felmlee-Devine D; Kamath PS; Smith GE
    Liver Int; 2010 Jul; 30(6):841-9. PubMed ID: 20412441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Zinc supplementation in patients with cirrhosis and hepatic encephalopathy: a systematic review and meta-analysis.
    Shen YC; Chang YH; Fang CJ; Lin YS
    Nutr J; 2019 Jul; 18(1):34. PubMed ID: 31279342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of GABAA receptors by neurosteroids. A new concept to improve cognitive and motor alterations in hepatic encephalopathy.
    Agusti A; Llansola M; Hernández-Rabaza V; Cabrera-Pastor A; Montoliu C; Felipo V
    J Steroid Biochem Mol Biol; 2016 Jun; 160():88-93. PubMed ID: 26307490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS.
    Gioia S; Merli M; Nardelli S; Lattanzi B; Pitocchi F; Ridola L; Riggio O
    Liver Int; 2019 May; 39(5):871-877. PubMed ID: 30667572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
    Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
    Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy.
    Felipo V
    World J Gastroenterol; 2006 Dec; 12(48):7737-43. PubMed ID: 17203513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cognitivity, proinflammatory cytokines, and brain magnetic resonance imaging in minimal hepatic encephalopathy induced by cirrhosis and extrahepatic portal vein obstruction.
    Yadav SK; Goel A; Saraswat VA; Thomas MA; Wang E; Marincola FM; Haris M; Gupta RK
    J Gastroenterol Hepatol; 2016 Dec; 31(12):1986-1994. PubMed ID: 27119420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid metabolomics highlights dysregulation of energy metabolism in overt hepatic encephalopathy.
    Weiss N; Barbier Saint Hilaire P; Colsch B; Isnard F; Attala S; Schaefer A; Amador MD; Rudler M; Lamari F; Sedel F; Thabut D; Junot C
    J Hepatol; 2016 Dec; 65(6):1120-1130. PubMed ID: 27520878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of cirrhosis III. Hepatic encephalopathy.
    Butterworth RF
    J Hepatol; 2000; 32(1 Suppl):171-80. PubMed ID: 10728803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The PHES battery does not detect all cirrhotic patients with early neurological deficits, which are different in different patients.
    Giménez-Garzó C; Garcés JJ; Urios A; Mangas-Losada A; García-García R; González-López O; Giner-Durán R; Escudero-García D; Serra MA; Soria E; Felipo V; Montoliu C
    PLoS One; 2017; 12(2):e0171211. PubMed ID: 28146589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy.
    Görg B; Karababa A; Shafigullina A; Bidmon HJ; Häussinger D
    Glia; 2015 Jan; 63(1):37-50. PubMed ID: 25092802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients].
    Yang CS; Cao SY; He XJ; Wang YX; Zhang YL
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):422-4. PubMed ID: 17631712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the tyrosine kinase inhibitors trigger metabolic encephalopathy in cirrhotic patients?
    Brandi G; de Rosa F; Calzà L; Girolamo SD; Tufoni M; Ricci CS; Cirignotta F; Caraceni P; Biasco G
    Liver Int; 2013 Mar; 33(3):488-93. PubMed ID: 23402614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients.
    Moscucci F; Nardelli S; Pentassuglio I; Pasquale C; Ridola L; Merli M; Riggio O
    Liver Int; 2011 Nov; 31(10):1505-10. PubMed ID: 22093325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.